
May 14, 2026
Rewiring T Cell Signals in Cancer
Researchers are developing programmable immune strategies that allow T cells to resist exhaustion and sustain anti‑tumor responses. Tumors survive in part by sending “don’t attack me” signals to T cells. Many current immunotherapies rely on antibody drugs to block these signals, but these treatments don’t work for all patients and can lose effectiveness over time. …








